Medicare Enrolled

Dr. Sang Tae Kim, DO

Family Medicine · Amarillo, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
1500 S COULTER ST, Amarillo, TX 79106
8064679777
In practice since 2006 (19 years)
NPI: 1144330762 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kim? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kim

Dr. Sang Tae Kim is a family medicine in Amarillo, TX, with 19 years in practice. Based on federal Medicare data, Dr. Kim performed 2,711 Medicare services across 1,506 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kim received a total of $307,077 from 67 pharmaceutical and/or device companies across 1572 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kim is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 9% volume in TX$ $307,077 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,711
Medicare services
Top 9% in TX for family medicine
1,506
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~143 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Chronic care management, first 20 min/month486$44$112
Office visit, established patient (30-39 min)369$83$262
Ceftriaxone antibiotic injection288$0$45
Office visit, established patient (20-29 min)221$55$177
Steroid injection (triamcinolone)209$1$40
Drug injection, under skin or into muscle176$9$60
Office visit, established patient, complex (40-54 min)170$115$352
Annual wellness visit, follow-up158$123$197
Chest X-ray, 2 views100$22$122
Annual depression screening98$18$20
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza53$54$80
Urinalysis, manual52$3$15
Bone density scan (DEXA)48$35$258
Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage33$21$40
Test to measure expiratory airflow and volume31$18$70
Flu vaccine administration31$30$56
Electrocardiogram (EKG), 12-lead30$8$60
Ultrasound study of arm and leg arteries30$49$212
Pneumonia vaccine administration22$30$56
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit22$158$287
X-ray of knee, 1-2 views14$19$100
Hip X-ray, 2-3 views13$33$128
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment13$157$210
X-ray of lower and sacral spine, 2-3 views11$25$114
Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)11$41$50
Pneumococcal vaccine, 13-valent11$253$322
Pneumococcal vaccine, 23-valent11$131$190
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$307,077
Total received (2018-2024)
Avg $43,868/year across 7 years
Top 0% in TX for family medicine
67
Companies
1,572
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$222,266 (72.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$69,252 (22.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,209 (5.0%)
Other
Charitable contributions, space rental, and other categories
$350 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$70,280
2023
$52,303
2022
$13,400
2021
$34,162
2020
$26,145
2019
$64,260
2018
$46,527

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Genentech USA, Inc.
$75,356
Axsome Therapeutics, Inc.
$69,272
AstraZeneca Pharmaceuticals LP
$46,031
Takeda Pharmaceuticals U.S.A., Inc.
$42,202
Amgen Inc.
$18,285
Phathom Pharmaceuticals, Inc.
$17,849
ABBVIE INC.
$14,543
Esperion Therapeutics, Inc.
$10,891
GlaxoSmithKline, LLC.
$1,489
Otsuka America Pharmaceutical, Inc.
$980
PFIZER INC.
$861
Novartis Pharmaceuticals Corporation
$684
Lilly USA, LLC
$675
Lundbeck LLC
$650
Teva Pharmaceuticals USA, Inc.
$582
Janssen Pharmaceuticals, Inc
$542
Novo Nordisk Inc
$539
ARBOR PHARMACEUTICALS, INC.
$485
Regeneron Healthcare Solutions, Inc.
$436
Bayer HealthCare Pharmaceuticals Inc.
$383
Baxter Healthcare
$350
Allergan Inc.
$258
Kowa Pharmaceuticals America, Inc.
$251
Biohaven Pharmaceuticals, Inc.
$232
Allergan, Inc.
$231
Medicure Pharma Inc.
$204
Abbott Laboratories
$194
SANOFI-AVENTIS U.S. LLC
$165
ITI, Inc.
$163
Eisai Inc.
$147
Bayer Healthcare Pharmaceuticals Inc.
$145
IDORSIA PHARMACEUTICALS US INC
$141
Boehringer Ingelheim Pharmaceuticals, Inc.
$141
Amarin Pharma Inc.
$140
Biohaven Pharmaceutical Holding Company Ltd.
$129
Promius Pharma LLC
$125
Arbor Pharmaceuticals, Inc.
$118
Merck Sharp & Dohme Corporation
$109
Merck Sharp & Dohme LLC
$86
E.R. Squibb & Sons, L.L.C.
$85
EISAI INC.
$78
Radius Health, Inc.
$73
AbbVie Inc.
$71
Upsher-Smith Laboratories LLC
$67
Orexigen Therapeutics, Inc.
$56
Avanir Pharmaceuticals, Inc.
$51
UPSHER-SMITH LABORATORIES LLC
$48
Antares Pharma, Inc.
$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$44
Sunovion Pharmaceuticals Inc.
$44
Optinose US, Inc.
$40
VIVUS LLC
$39
Nalpropion Pharmaceuticals, Inc.
$39
Horizon Pharma plc
$30
Bolton Medical Inc
$26
Medtronic, Inc.
$21
Nalpropion Pharmaceuticals LLC
$19
VIVUS, Inc.
$19
Zyla Life Sciences, Inc.
$14
Vanda Pharmaceuticals Inc.
$14
Alvogen Inc
$14
Duchesnay USA Incorporated
$14
Neurelis, Inc.
$13
Astellas Pharma US Inc
$13
Ironshore Pharmaceuticals Inc.
$13
Adlon Therapeutics L.P.
$12
RedHill Biopharma Inc.
$11
Top 3 companies account for 62.1% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADHANSIA XR · AIMOVIG · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · AirDuo Digihaler · Auvelity · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BYDUREON · BYSTOLIC · Belviq · Bonjesta · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · Corlanor · DIABETES - DISEASE · DUEXIS · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · Edarbyclor · Evekeo · Evekeo ODT · FANAPT · FARXIGA · FASENRA · FREESTYLE LIBRE 3 · GALLANT · HMG-CoA reductase inhibitor. · Horizant · INTELLIS ADAPTIVESTIM · INVEGA SUSTENNA · INVOKANA · JANUVIA · JARDIANCE · JORNAY PM · JOT DX · Kerendia · LATUDA · LEQVIO · LO LOESTRIN FE · LONHALA MAGNAIR · LYRICA · Livalo · MOUNJARO · Motegrity · NEXLETOL · NEXLIZET · NUEDEXTA · NURTEC ODT · OTREXUP · Otezla · Ozempic · PAXLOVID · PENNSAID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QSYMIA · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · REXULTI · REYVOW · Repatha · SAMSCA · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · SPRIX · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TERIPARATIDE · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TOUJEO · TRELEGY ELLIPTA · TREO ABDOMINAL STENT-GRAFT SYSTEM · TRINTELLIX · TRULICITY · TRUMENBA · Talicia · Trintellix · Tymlos · UBRELVY · Uloric · VALTOCO · VOQUEZNA · VRAYLAR · VYEPTI · VYVANSE · Vascepa · Veozah · Vyvanse · Wegovy · XARELTO · XYOSTED · Xhance · Xofluza · ZEPBOUND · ZYPITAMAG · ZYPITAMAG (pitavastatin) · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in family medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for family medicine in TX.

Equivalent to $11,327 per 100 Medicare services performed
Looking for a family medicine in Amarillo?
Compare family medicines in the Amarillo area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
118
Per 100K population
101.2
County median income
$50,448
Nearest hospital
NORTHWEST TEXAS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kim is a clinical cardiology specialist, with above-average Medicare volume (top 9% in TX), and high industry engagement (speaking/promotional, top 0%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kim experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Kim performed 486 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kim receive payments from pharmaceutical companies?
Yes. Dr. Kim received a total of $307,077 from 67 companies across 1,572 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kim's costs compare to other family medicines in Amarillo?
Dr. Kim's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →